BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Toxikon to Hold Medical Device and Testing Seminar Next Month


3/27/2008 8:08:18 AM

BEDFORD, Mass., March 26 /PRNewswire/ -- Toxikon Corporation will host their second annual medical device and testing seminar April 17 at their headquarters in Bedford, Massachusetts.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071228/TOXIKONLOGO )

As safety-testing guidelines continue to be updated and revised, medical device manufacturers must address the testing requirements appropriate for their product. With new innovations and applications in development, testing guidelines can be vague, requiring device manufacturers to implement timely and cost-effective testing programs.

The seminar will review considerations in ISO and MHLW biocompatibility testing, as well as recent trends in extractables/leachable and microbiological evaluations.

Toxikon employees scheduled to speak at this popular event include Laurence Lister, Director of Biocompatibility; Dr. Stephen Doherty, Study Director for Chemistry; and Dr. Sharon Malia, Study Director for Microbiology. Workshops will immediately follow the three presentations.

Registration cost is $465 per person and is open to medical device industry professionals, particularly those involved in research and development, quality assurance, regulatory affairs and design engineering. Breakfast and lunch is included.

Due to popular demand, the event is limited to no more than two representatives per company. Registration is on a first-come, first-served basis and will be limited to 40 people.

For more information, contact Joann Hoxha at (800) 458-4141 or e-mail seminar@toxikon.com.

Toxikon Corporation is an ISO 17025-certified global Contract Research Organization (CRO) that conducts compliance studies for the medical device and biopharmaceutical industries, as well as academic research centers.



CONTACT: Joann Hoxha of Toxikon Corporation, +1-800-458-4141,
seminar@toxikon.com

Web site: http://www.toxikon.com//



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES